Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: JAMA Psychiatry. 2013 Nov;70(11):1152–1160. doi: 10.1001/jamapsychiatry.2013.1969

Table 1.

Pretreatment Demographic and Clinical Characteristics of Cognitive Therapy Responders Presenting with Recurrent Major Depressive Disorders

Domain Characteristics Total
(n=241)
PBO
(n=69)
FLX
(n=86)
C-CT
(n=86)

Demographic Sex, No (%) female 162 (67.2) 42 (60.9) 57 (66.3) 63 (73.3)
Race, No (%) white 205 (85.1) 62 (89.9) 72 (83.7) 71 (82.6)
Age, mean (SD) 42.7 (11.8) 43.6 (12.3) 41.6(11.8) 43.1 (11.5)
Marital status, No (%)
  Single 138 (57.3) 36 (52.2) 56 (65.1) 46 (53.5)
  Partnered 103 (42.7) 33 (47.8) 30 (34.9) 40 (46.5)
Education, mean (SD) 15.7 (2.9) 15.3 (3.1) 16.0(3.0) 15.7 (2.7)
Employment, No (%)
  Full time 120 (49.8) 35 (50.7) 44 (51.2) 41 (47.7)
  Part time 28 (11.6) 9 (13.0) 12 (14.0) 7 (8.1)
  Homemaker/Caregiver 18 (7.5) 5 (7.3) 4 (4.7) 9 (10.5)
  Student 14 (5.8) 2 (2.9) 6 (7.0) 6 (7.0)
  Retired 9 (3.7) 2 (2.9) 5 (5.8) 2 (2.3)
  Other 13 (5.4) 4 (5.8) 3 (3.5) 6 (7.0)
  Unemployed 39 (16.2) 12 (17.4) 12 (14.0) 15 (17.4)
Severity and Clinical HRSD17 Depression Severity Scores, mean (SD)
  At final pre-treatment follow-up 20.0 (3.9) 20.4 (3.9) 19.9(3.9) 19.9(4.0)
  At randomization 7.5 (3.4) 7.4 (3.0) 7.5(3.6) 7.5(3.4)
Age at onset, in years, Median 18.0 19.0 17.0 19.5
Length of current episode in months, Median, ¥, , § 9.0 9.0 6.0 12.5
Length of illness in years, Median 20.0 19.0 20.5 21.0
No. of episodes, median 4.0 3.0 4.0 4.0
Comorbid DSM-IV diagnoses, No (%)
  Current 96 (39.8) 26 (37.7) 37 (43.0) 33 (38.4)
  Lifetime 181 (75.1) 51 (73.9) 67 (77.9) 63 (73.3)
Depressive subtype – N (%) 11 (4.6) 2 (2.9) 5 (5.8) 4 (4.7)
  RDC endogenous, definite 84 (35.2) 26 (38.2) 34 (40.0) 24 (27.9)
  DSM-IV melancholia 85 (35.6) 22 (32.8) 37 (43.0) 26 (30.2)
¥

: p ≤ .05 for comparing the patients in the three groups (PBO, FLX, and C-CT).

: p ≤ .05 for comparing the patients in the PBO and FLX groups.

: p ≤ .05 for comparing the patients in the PBO and C-CT groups.

§

: p ≤ .05 for comparing the patients in the FLX and C-CT groups.